Bc9.co
Fat Loss, Metabolism & Nootropics
Examine the compounds behind metabolic and cognitive enhancement in laboratory models. This series dives into the science of AOD-9604, Semaglutide, Semax, and more—where performance meets precision.
Bezoek zeker de website van de podcast en steun de maker: bc9.co
Auteur
Bc9.co
Categorie
Website van de podcast
Nieuwste aflevering
29 okt. 2025
Waar luisteren?
Podcasts in de app Replaio Radio Binnenkort beschikbaarPodcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts
Afleveringen
Why Source Integrity Matters: Peptides & Nootropics in Research Use 29.10.2025 14:54
In the world of scientific exploration, the accuracy of any research outcome depends heavily on the purity, consistency, and traceability of the materials being studied. Whether researchers are working with peptides or nootropics, the integrity of the source defines the reliability of the data. Poor-quality compounds can compromise entire studies, distort results, and lead to … Read More "Wh...
The Nootropic Edge: Semax, Selank, and the Future of Brain Research 29.10.2025 15:02
The landscape of brain research is evolving rapidly. As neuroscientists explore new ways to influence focus, mood, memory formation, and cognitive resilience, a new class of compounds has emerged at the forefront of nootropic investigation: peptides. Among them, Semax and Selank stand out as two of the most compelling subjects of interest for research into … Read More "The Nootropic Edge: Se...
AOD-9604, Tesamorelin, and Semaglutide: Inside Metabolic Studies 29.10.2025 14:33
Metabolic health is central to many areas of biomedical research—obesity, type 2 diabetes, visceral fat accumulation, non-alcoholic fatty liver disease, and more. Three compounds that are frequently under study for their promising effects on metabolism are AOD-9604, Tesamorelin, and Semaglutide. Each operates through different mechanisms, has distinct research findings, and carries varying degrees...
Vergelijkbare podcasts
Replaio is geen uitgever van podcasts; namen van shows, covers en audio zijn eigendom van hun makers en worden verspreid via openbare RSS-feeds